# Demis Hassabis

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/demis-hassabis
Canonical HTML page: https://getbiobrief.com/entity/demis-hassabis

## Recent coverage (2 stories)

### AlphaFold 200M Structures at a Crossroads as Jumper Joins Anthropic
2026-06-20 15:33:34 · Sentiment: Neutral · Impact: 7/10 · Sources: 3

Nobel laureate John Jumper’s move from Google DeepMind to Anthropic casts uncertainty over the future of AlphaFold, the AI that revolutionized protein structure prediction for drug discovery. Biotech and pharma companies relying on its 200 million predicted structures now watch as Jumper’s expertise may shift to a startup facing legal battles.
Full story: https://getbiobrief.com/story/jumper-anthropic-biotech-ai

### AGI Arrival in 5-8 Years: DeepMind CEO Signals 'Golden Era' for Biotech R&D
2026-02-18 18:03:38 · Sentiment: Positive · Impact: 8/10 · Sources: 4

Google DeepMind CEO Demis Hassabis predicts Artificial General Intelligence (AGI) could arrive within five to eight years, ushering in a 'golden era of science' for drug discovery. While the timeline suggests a radical acceleration of biological engineering, Hassabis issued urgent warnings regarding biosecurity risks as AI systems gain autonomous capabilities.
Full story: https://getbiobrief.com/story/agi-timeline-deepmind-biotech-impact-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.